| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 85.89 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 85.89. The average price that SAN.PA shares were previous bought at was EUR 87.0629. The current market price is -1.3% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 355,653 compared to the previous valuation of Sanofi SA |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 115.8 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 115.8. The average price that MRK.DE shares were previous bought at was EUR 117.714. The current market price is -1.6% lower than average price they were purchased at. The value of the holding in MRK.DE has increased by EUR 6,139 compared to the previous valuation of Merck KGaA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 112.077 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 112.077. The average price that NOVN.SW shares were previous bought at was CHF 104.173. The current market price is 7.6% higher than average price they were purchased at. The value of the holding in NOVN.SW has fallen by CHF 1,250,550 compared to the previous valuation of |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 41.626 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 41.626. The average price that NOVO-B.CO shares were previous bought at was DKK 54.484. The current market price is -23.6% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 1,352,388 compared to the previous valuation of Novo Nordisk A/S |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 61.65 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 61.65. The average price that ORNBV.HE shares were previous bought at was EUR 59.6591. The current market price is 3.3% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 72,381 compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 24.23 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 24.23. The average price that PHIA.AS shares were previous bought at was EUR 22.3418. The current market price is 8.5% higher than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 21,926 compared to the previous valuation of Koninklijke Philips NV |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 41.445 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 41.445. The average price that QIA.DE shares were previous bought at was EUR 39.6333. The current market price is 4.6% higher than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 67,876 compared to the previous valuation of QIAGEN NV |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 50.5 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 50.5. The average price that REC.MI shares were previous bought at was EUR 52.7785. The current market price is -4.3% lower than average price they were purchased at. The value of the holding in REC.MI has fallen by EUR 5,456 compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA |
| RO.SW - | HOLD | 0 @ CHF 343.17 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 343.17. The average price that RO.SW shares were previous bought at was CHF 303.671. The current market price is 13.0% higher than average price they were purchased at. The value of the holding in RO.SW has fallen by CHF 141,797 compared to the previous valuation of |
| ROG.SW - | HOLD | 0 @ CHF 331.281 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 331.281. The average price that ROG.SW shares were previous bought at was CHF 288.357. The current market price is 14.9% higher than average price they were purchased at. The value of the holding in ROG.SW has fallen by CHF 2,540,899 compared to the previous valuation of |
| LONN.SW - | HOLD | 0 @ CHF 585.66 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 585.66. The average price that LONN.SW shares were previous bought at was CHF 603.8. The current market price is -3.0% lower than average price they were purchased at. The value of the holding in LONN.SW has increased by CHF 417,289 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SDZ.SW - | HOLD | 0 @ CHF 60.1726 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 60.1726. The average price that SDZ.SW shares were previous bought at was CHF 46.7248. The current market price is 28.8% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 11,084 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 42.74 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 42.74. The average price that SHL.DE shares were previous bought at was EUR 47.2525. The current market price is -9.5% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 122,083 compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 14.3876 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 14.3876. The average price that SN.L shares were previous bought at was GBP 13.6935. The current market price is 5.1% higher than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 20,454 compared to the previous valuation of Smith & Nephew PLC |
| SOBI.ST - | HOLD | 0 @ SEK 31.259 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 31.259. The average price that SOBI.ST shares were previous bought at was SEK 26.7367. The current market price is 16.9% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 53,899 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 215.499 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 215.499. The average price that SOON.SW shares were previous bought at was CHF 261.073. The current market price is -17.5% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 106,524 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 245.4 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 245.4. The average price that SRT3.DE shares were previous bought at was EUR 216.573. The current market price is 13.3% higher than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 87,272 compared to the previous valuation of Sartorius AG however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| STMN.SW - | HOLD | 0 @ CHF 100.145 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 100.145. The average price that STMN.SW shares were previous bought at was CHF 110.05. The current market price is -9.0% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 139,199 compared to the previous valuation of |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 209 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 209. The average price that TUB.BR shares were previous bought at was EUR 208.5. The current market price is 0.2% higher than average price they were purchased at. The value of the holding in TUB.BR has increased by EUR 9,484 compared to the previous valuation of Financiere de Tubize SA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 238.5 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 238.5. The average price that UCB.BR shares were previous bought at was EUR 189.296. The current market price is 26.0% higher than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 83,976 compared to the previous valuation of UCB SA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 41.14 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 41.14. The average price that FME.DE shares were previous bought at was EUR 46.0402. The current market price is -10.6% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 16,749 compared to the previous valuation of Fresenius Medical Care AG |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 790.8 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 790.8. The average price that ARGX.BR shares were previous bought at was EUR 582.972. The current market price is 35.6% higher than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 384,767 compared to the previous valuation of Argenx SE |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 160.127 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 160.127. The average price that AZN.L shares were previous bought at was GBP 132.041. The current market price is 21.3% higher than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 1,970,938 compared to the previous valuation of AstraZeneca PLC |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 30.62 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 30.62. The average price that BAYN.DE shares were previous bought at was EUR 25.3945. The current market price is 20.6% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 242,360 compared to the previous valuation of Bayer AG however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 109.3 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 109.3. The average price that BIM.PA shares were previous bought at was EUR 114.309. The current market price is -4.4% lower than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 27,315 compared to the previous valuation of BioMerieux |
| COLO-B.CO - | HOLD | 0 @ DKK 78.2178 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 78.2178. The average price that COLO-B.CO shares were previous bought at was DKK 83.2876. The current market price is -6.1% lower than average price they were purchased at. The value of the holding in COLO-B.CO has increased by DKK 18,903 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| DEMANT.CO - | HOLD | 0 @ DKK 29.3216 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 29.3216. The average price that DEMANT.CO shares were previous bought at was DKK 32.3177. The current market price is -9.3% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 4,775 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 203 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 203. The average price that DIM.PA shares were previous bought at was EUR 192.699. The current market price is 5.3% higher than average price they were purchased at. The value of the holding in DIM.PA has increased by EUR 58,395 compared to the previous valuation of Sartorius Stedim Biotech however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 313.1 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 313.1. The average price that EL.PA shares were previous bought at was EUR 262.64. The current market price is 19.2% higher than average price they were purchased at. EUR 0 compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 59.24 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 59.24. The average price that ERF.PA shares were previous bought at was EUR 57.6359. The current market price is 2.8% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 20,149 compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| ALC.SW - | HOLD | 0 @ CHF 68.4841 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 68.4841. The average price that ALC.SW shares were previous bought at was CHF 73.9456. The current market price is -7.4% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 6,636 compared to the previous valuation of |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 47.36 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 47.36. The average price that FRE.DE shares were previous bought at was EUR 42.6257. The current market price is 11.1% higher than average price they were purchased at. The value of the holding in FRE.DE has fallen by EUR 12,026 compared to the previous valuation of Fresenius SE & Co KGaA |
| GALD.SW - | HOLD | 0 @ CHF 170.835 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 170.835. The average price that GALD.SW shares were previous bought at was CHF 131.959. The current market price is 29.5% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 144,070 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 271.928 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 271.928. The average price that GMAB.CO shares were previous bought at was DKK 208.275. The current market price is 30.6% higher than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 162,964 compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 10.59 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 10.59. The average price that GRF.MC shares were previous bought at was EUR 10.6781. The current market price is -0.8% lower than average price they were purchased at. The value of the holding in GRF.MC has increased by EUR 30,971 compared to the previous valuation of Grifols SA however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 20.593 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 20.593. The average price that GSK.L shares were previous bought at was GBP 17.3833. The current market price is 18.5% higher than average price they were purchased at. The value of the holding in GSK.L has fallen by GBP 423,240 compared to the previous valuation of GlaxoSmithKline PLC |
| HIK.L - | HOLD | 0 @ GBP 17.9417 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 17.9417. The average price that HIK.L shares were previous bought at was GBP 22.4354. The current market price is -20.0% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 21,830 compared to the previous valuation of however if the holding was sold on 2025-11-27 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.2283 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.2283. The average price that HLN.L shares were previous bought at was GBP 4.40172. The current market price is -3.9% lower than average price they were purchased at. The value of the holding in HLN.L has fallen by GBP 30,267 compared to the previous valuation of Haleon PLC |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 124.4 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 124.4. The average price that IPN.PA shares were previous bought at was EUR 110.413. The current market price is 12.7% higher than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 21,484 compared to the previous valuation of Ipsen SA |